CIK 0001453687
- Non-accelerated filer
- Smaller reporting company
Cartesian Therapeutics, Inc.
Sign in to watch- Ticker
- RNAC
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- Phone
- +1 301-348-8698
- Business address
- 7495 NEW HORIZON WAY, FREDERICK, MD, 21703
- Former names
- SELECTA BIOSCIENCES INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-01-10 | Jewell Christopher M Chief Scientific Officer | Exercise or conversion | +9,000 | $3.23 | $29K | 62,490 |
| 2025-01-10 | Jewell Christopher M Chief Scientific Officer | Exercise or conversion · Stock Option (Right to Buy) | −9,000 | 67,432 | ||
| 2025-01-06 | Jewell Christopher M Chief Scientific Officer | Sale | −1,286 | $16.83 | $22K | 53,490 |
| 2025-01-03 | Jewell Christopher M Chief Scientific Officer | Sale | −1,264 | $16.72 | $21K | 54,776 |
| 2025-01-02 | Jewell Christopher M Chief Scientific Officer | Grant or award | +16,100 | 56,040 | ||
| 2025-01-02 | Jewell Christopher M Chief Scientific Officer | Grant or award · Employee Stock Option (right to buy) | +47,400 | 47,400 | ||
| 2024-11-20 | Jewell Christopher M Chief Scientific Officer | Exercise or conversion | +14,000 | $3.23 | $45K | 39,940 |
| 2024-11-20 | Jewell Christopher M Chief Scientific Officer | Exercise or conversion · Stock Option (Right to Buy) | −14,000 | 76,432 | ||
| 2024-11-15 | Jewell Christopher M Chief Scientific Officer | Exercise or conversion | +16,065 | $3.23 | $52K | 42,005 |
| 2024-11-15 | Jewell Christopher M Chief Scientific Officer | Sale | −16,065 | $17.06 | $274K | 25,940 |
| 2024-11-15 | Jewell Christopher M Chief Scientific Officer | Exercise or conversion · Stock Option (Right to Buy) | −16,065 | 90,432 | ||
| 2024-11-14 | Jewell Christopher M Chief Scientific Officer | Exercise or conversion | +36,050 | $3.23 | $116K | 61,990 |
| 2024-11-14 | Jewell Christopher M Chief Scientific Officer | Sale | −18,550 | $16.34 | $303K | 43,440 |
| 2024-11-14 | Jewell Christopher M Chief Scientific Officer | Sale | −17,500 | $17.02 | $298K | 25,940 |
| 2024-11-14 | Jewell Christopher M Chief Scientific Officer | Exercise or conversion · Stock Option (Right to Buy) | −36,050 | 106,497 | ||
| 2024-04-08 | Jewell Christopher M Chief Scientific Officer | Exercise or conversion · Stock Option (Right to Buy) | −4,276.45 | 0 | ||
| 2024-04-08 | Jewell Christopher M Chief Scientific Officer | Exercise or conversion · Stock Option (Right to Buy) | +142,547 | 142,547 | ||
| 2024-01-02 | Jewell Christopher M Chief Scientific Officer | Grant or award | +778,200 | 778,200 | ||
| 2024-01-02 | Jewell Christopher M Chief Scientific Officer | Grant or award · Employee Stock Option (right to buy) | +998,000 | 998,000 | ||
| 2023-11-13 | Jewell Christopher M Chief Scientific Officer | Grant or award · Stock Option (Right to Buy) | +4,276.45 | 4,276.45 |
Page 1 of 1 · 20 trades